Re: AACR 2018
|
1
|
Zenith Epigenetics
|
Feb 27, 2018 08:43PM
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 23, 2018 02:54AM
|
Re: AACR
|
1
|
Zenith Epigenetics
|
Apr 01, 2019 05:52PM
|
Re: AACR
|
2
|
Zenith Epigenetics
|
Apr 01, 2019 08:25PM
|
Re: A Wing and a Prayer
|
5
|
Resverlogix Corp.
|
Sep 21, 2019 03:59AM
|
Re: A Wing and a Prayer
|
4
|
Resverlogix Corp.
|
Sep 21, 2019 04:12AM
|
Re: A whole slew of expired options reported at Canadianinsider:
|
2
|
Resverlogix Corp.
|
Jul 14, 2018 11:23AM
|
Re: A whole slew of expired options reported at Canadianinsider:
|
1
|
Resverlogix Corp.
|
Jul 14, 2018 02:20PM
|
Re: A whole new level...
|
6
|
Resverlogix Corp.
|
Sep 27, 2019 02:10PM
|
Re: A view on google trends for resverlogix
|
3
|
Resverlogix Corp.
|
Sep 28, 2019 06:52PM
|
Re: A view on google trends for resverlogix
|
2
|
Resverlogix Corp.
|
Sep 28, 2019 07:50PM
|
Re: A view on google trends for resverlogix
|
3
|
Resverlogix Corp.
|
Sep 29, 2019 02:52AM
|
Re: A taxable versus a non taxable sale
|
2
|
Zenith Epigenetics
|
Sep 13, 2018 12:14AM
|
Re: A Special Meeting of Shareholders?
|
5
|
Resverlogix Corp.
|
Jun 06, 2024 05:27PM
|
Re: A Shenzhen Hepalink M&A type deal...
|
2
|
Resverlogix Corp.
|
Jan 07, 2018 12:18PM
|
Re: A Shenzhen Hepalink M&A type deal...
|
2
|
Resverlogix Corp.
|
Jan 07, 2018 01:38PM
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
2
|
Resverlogix Corp.
|
Oct 26, 2020 08:55PM
|
Re: A Question for all here, the frustrated people, the P.O people, the content people & the koolaid people.....
|
3
|
Resverlogix Corp.
|
Jan 09, 2021 04:47PM
|
Re: A Question for all here, the frustrated people, the P.O people, the content people & the koolaid people.....
|
2
|
Resverlogix Corp.
|
Jan 09, 2021 07:24PM
|
Re: A Question for all here, the frustrated people, the P.O people, the content people & the koolaid people.....
|
6
|
Resverlogix Corp.
|
Jan 10, 2021 04:01PM
|